WALTHAM, Mass., May 08, 2020 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) a global biopharmaceutical company pioneering targeted C3 therapies, […]
GAITHERSBURG, Md., May 08, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it […]
DUBLIN, Ireland, May 08, 2020 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization […]
MALVERN, Pa., May 08, 2020 (GLOBE NEWSWIRE) — Recro Pharma, Inc. (NASDAQ:REPH) a leading contract development and manufacturing organization (CDMO), […]